Calcitriol derivatives with two different side chains at C-20. II. Diastereoselective syntheses of the metabolically produced 24(R)-hydroxygemini

Journal of Medicinal Chemistry

Volumn 47, Issue 26, 2004, Pages 6476-6484

  Maehr, Hubert ^a   Uskokovic, Milan R ^a   Adorini, Luciano ^a   Reddy, G Satyanarayana ^a,b  

^a Bioxell Inc   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

19 NORCALCITRIOL; CALCITRIOL DERIVATIVE; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG TOLERANCE; EPIMER; MOUSE; NONHUMAN; RAT; STEREOCHEMISTRY; STEREOSPECIFICITY; SYNTHESIS;

ANIMALS; CALCITRIOL; CALCIUM; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROXYLATION; INTERFERON TYPE II; MICE; RATS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 10644257331     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049340b     Document Type: Article

References (22)

1. This paper was presented in part at the 12th Workshop on Vitamin D, July 6-10, 2003, Maastricht, The Netherlands, Abstracts, p 41. Part I: Reference 18.
2. 3 analogue with two side chains. In Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; University of California: Riverside, 1997; pp 19-21.
3. 3 analogs with bis-C-20 side chains for treating or preventing neoplastic diseases, US 6008209, 1999, 13 pp.
4. 3 analogs with bis-C-20 side chains as therapeutic agents, WO 9849138 1998, 35 pp.
5. 3 with two side chains: Interaction with its nuclear receptor and cellular actions. J. Med. Chem. 2000, 43, 2719-2730.
6. Rao, S.; Balkundi, D.; Uskokovic, M. R.; Tserng, K.-Y.; Clark, J. W.; Horst, R. L.; Reddy, G. S. Double bond in the side chain of 1α,25- dihydroxy-22-ene-vitamin D3 is reduced during its metabolism: Studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney. J. Steroid Biochem. Mol. Biol. 2001, 78, 167-176.
7. 3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity J. Steroid Biochem. Mol. Biol. 1999, 71, 111-121.
8. Uskokovic, M. R.; Norman, A. W.; Manchand, P. S.; Studzinski, G. P.; Campbell, M. J.; Koefller, H. P.; Takeuchi, A.; Siu-Caldera, M.-L.; Rao, D. S.; Reddy, G. S. Highly active analogs of 1α,25-dihydroxy-vitamin D3 that resist metabolism through C-24 oxidation and C3 epimerization pathways. Steroids 2001, 66, 463-471.
9. 3 produced in rat kidney. Biochem. Pharmacol. 1999, 58, 1965-1973.
10. 2 produced in rat kidney. Biochemistry 1986, 25, 5328-5336.
11. 3. Biochemistry 1987, 26, 324-331.
12. 3 through C-24 oxidation pathway. Biochemistry 1989, 28, 1763-1769.
13. 3 related compound with potential therapeutic activity. Tetrahedron Lett. 1990, 31, 1823-1824.
14. (b) DeLuca, H. F.; Schnoes, H. K.; Perlman, K. L. Preparation of intermediates for the synthesis of 19-nor-vitamin D compounds. US 5086191, 1992.
15. (c) Deluca, H. F.; Schnoes, H. K.; Perlman, K. L.; Swenson, R. E. Novel synthesis of 19-nor-vitamin D compounds. EP 516410, 1992.
16. Chemical structures are drawn according to a proposed convention: Maehr, H. Graphic representation of configuration in two-dimensional space. Current conventions, clarifications, and proposed extensions. J. Chem. Inf. Comput. Sci. 2002, 42, 894-902.
17. Lythgoe, B. Synthetic approaches to vitamin D and its relatives. Chem. Soc. Rev. 1981, 10, 449-475.
18. Zhu, G.-D.; Okamura, W. H. Synthesis of vitamin D (calciferol). Chem. Rev. 1995, 95, 1877-1952.
19. Baggiolini, E. G.; Iacobelli, J. A.; Hennessy, B. M.; Batcho, A. D.; Sereno, J. F.; Uskokovic, M. R. Stereocontrolled total synthesis of 1α,25-dihydroxycholecalciferol and 1α,25-dihydroxyergocalciferol. J. Org. Chem. 1986, 51, 3098-3108.
20. Maehr, H.; Uskokovic, M. R.; Norman, A.; Bishop, J.; Reddy, G. S.; Koeffler, P.; Studzinski, G. DeLuca Symposium on Vitamin D, Taos, New Mexico, June 15-19, 2002, Abstract p 42.
21. Maehr, H.; Uskokovic, M. R. Formal desymmetrization of the diastereomeric chains in gemini calcitriol derivatives with two different side chains at C-20. Eur. J. Org. Chem. 2004, 1703-1713.
22. 3 (24-hydroxylated ED-71). Steroids 2000, 66, 267-276.